Sale!

Leukemia Genetic Profile – Any 6 Markers PCR Qualitative Test

Original price was: $376.Current price is: $238.

-37%

The Leukemia Genetic Profile – Any 6 Markers PCR Qualitative Test is a sophisticated molecular diagnostic tool that identifies specific genetic abnormalities associated with leukemia. This advanced PCR-based test analyzes any 6 selected genetic markers from a comprehensive panel including BCR-ABL, PML-RARA, AML-ETO, and other critical leukemia-associated mutations. The test provides crucial information for accurate leukemia classification, prognosis assessment, and treatment selection. It’s particularly valuable for patients with suspected or confirmed leukemia, helping oncologists develop targeted treatment strategies. Results are typically available within 2-4 business days, with discounted pricing at $238 USD compared to the regular $376 USD cost. This test represents a significant advancement in personalized leukemia care.

Trusted Testing. Expert Care. Guaranteed Privacy.

  • Accredited and Trusted
  • Expert Scientists, Advanced Technology
  • Data Privacy Guaranteed
Guaranteed Safe Checkout

Leukemia Genetic Profile – Any 6 Markers PCR Qualitative Test

Comprehensive Introduction to Leukemia Genetic Testing

The Leukemia Genetic Profile – Any 6 Markers PCR Qualitative Test represents a cutting-edge advancement in molecular diagnostics for leukemia management. This sophisticated test utilizes real-time PCR technology to detect specific genetic abnormalities that are crucial for accurate leukemia classification and treatment planning. By analyzing up to six selected genetic markers from a comprehensive panel, this test provides invaluable insights into the molecular characteristics of leukemia cells, enabling healthcare providers to develop personalized treatment strategies tailored to each patient’s unique genetic profile.

What This Advanced Test Measures and Detects

This comprehensive genetic profile test specifically targets and identifies key leukemia-associated genetic markers through highly sensitive PCR methodology. The test panel includes:

Acute Myeloid Leukemia (AML) Markers:

  • BCR-ABL fusion gene
  • PML-RARA translocation
  • AML-ETO rearrangement
  • INV16 inversion
  • NPM1 mutations
  • FLT3 mutations

Acute Lymphoblastic Leukemia (ALL) Markers:

  • BCR-ABL fusion gene
  • MLL-AF9 translocation
  • MLL-AF4 rearrangement
  • MLL-ENL fusion
  • t(12;21) translocation
  • t(1;19) translocation

Each marker provides critical information about leukemia subtype, prognosis, and potential response to targeted therapies.

Who Should Consider This Genetic Profile Test

This advanced leukemia genetic testing is recommended for individuals experiencing:

  • Unexplained fatigue, weakness, or persistent tiredness
  • Frequent infections or unusual susceptibility to illness
  • Unexplained bruising, bleeding, or petechiae
  • Bone pain or tenderness
  • Enlarged lymph nodes, spleen, or liver
  • Unexplained weight loss or night sweats
  • Abnormal blood counts detected during routine testing
  • Family history of hematological malignancies
  • Patients with newly diagnosed leukemia requiring precise classification
  • Individuals undergoing leukemia treatment monitoring

Significant Benefits of Leukemia Genetic Profiling

Undergoing this comprehensive genetic testing provides numerous advantages:

  • Precise Diagnosis: Accurate identification of specific leukemia subtypes
  • Personalized Treatment: Guidance for targeted therapy selection
  • Prognostic Information: Assessment of disease aggressiveness and likely outcomes
  • Treatment Monitoring: Ability to track treatment response and detect minimal residual disease
  • Risk Stratification: Identification of high-risk genetic features requiring intensive therapy
  • Clinical Trial Eligibility: Determination of suitability for specific clinical trials
  • Family Counseling: Information for genetic counseling when applicable

Understanding Your Test Results

Your leukemia genetic profile results will be carefully interpreted by our expert molecular pathologists and hematologists. Positive results indicate the presence of specific genetic abnormalities associated with particular leukemia subtypes. Negative results suggest the absence of the tested markers in your sample. It’s crucial to discuss your results with your oncologist or hematologist, who will integrate this genetic information with other clinical findings to develop your comprehensive treatment plan. Remember that genetic testing provides one piece of the diagnostic puzzle and should be considered alongside complete blood counts, bone marrow examination, and other relevant clinical information.

Test Pricing and Availability

Test Name Discount Price Regular Price
Leukemia Genetic Profile – Any 6 Markers PCR Qualitative Test $238 USD $376 USD

Nationwide Testing Availability

We proudly offer this advanced leukemia genetic testing service across our nationwide network of testing centers. Our facilities are conveniently located in major metropolitan areas including New York, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, and San Jose. With consistent quality standards and rapid turnaround times, patients throughout the United States can access this cutting-edge diagnostic technology.

Take Control of Your Leukemia Management Today

Don’t leave your leukemia diagnosis and treatment to chance. Our Leukemia Genetic Profile – Any 6 Markers PCR Qualitative Test provides the critical genetic information needed for optimal treatment decisions. With our discounted pricing at only $238 USD and comprehensive nationwide availability, there’s no reason to delay this essential testing.

Call or WhatsApp us today at +1(267) 388-9828 to schedule your leukemia genetic profile test and take the first step toward personalized, targeted leukemia care.

Our experienced genetic counselors and customer service representatives are available to answer your questions, help you select the appropriate genetic markers for your specific situation, and guide you through the testing process. Early and accurate genetic profiling can make a significant difference in leukemia treatment outcomes and quality of life.